SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bajaj Healthcare rises on acquiring Genrx Pharmaceuticals

08 Apr 2025 Evaluate

Bajaj Healthcare is currently trading at Rs. 575.00, up by 5.05 points or 0.89% from its previous closing of Rs. 569.95 on the BSE.

The scrip opened at Rs. 589.10 and has touched a high and low of Rs. 598.55 and Rs. 571.00 respectively. So far 18589 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 5 has touched a 52 week high of Rs. 744.90 on 19-Mar-2025 and a 52 week low of Rs. 265.00 on 04-Jun-2024.

Last one week high and low of the scrip stood at Rs. 701.00 and Rs. 507.65 respectively. The current market cap of the company is Rs. 1819.20 crore.

The promoters holding in the company stood at 59.19%, while Institutions and Non-Institutions held 3.37% and 37.45% respectively.

Bajaj Healthcare has successfully acquired Genrx Pharmaceuticals (in Liquidation) as a going concern, as per the Sale Certificate dated April 4, 2025, issued by the Official Liquidator. The acquisition, valued at Rs 10.85 crore through a cash consideration, involves 100% control of the target entity.

Bajaj Healthcare mainly focuses on development, manufacturing and supply of Amino Acids, Nutritional Supplements and Active Pharmaceutical Ingredients (API) for Pharmaceutical, Nutraceuticals and Food industries.

Bajaj Healthcare Share Price

348.95 -1.50 (-0.43%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×